Literature DB >> 7890415

Human T-cell responses to secreted antigen fractions of Mycobacterium tuberculosis.

H Boesen1, B N Jensen, T Wilcke, P Andersen.   

Abstract

The T-cell response of human donors to secreted antigen fractions of Mycobacterium tuberculosis was investigated. The donors were divided into five groups: active pulmonary tuberculosis (TB) patients with minimal and with advanced disease, Mycobacterium bovis BCG-vaccinated donors with and without contact with TB patients, and nonvaccinated individuals. We found that patients with active minimal TB responded powerfully to secreted antigens contained in a short-term culture filtrate. The response to secreted antigens was mediated by CD4+ Th-1-like lymphocytes, and the gamma interferon release by these cells was markedly higher in patients with active minimal TB than in healthy BCG-vaccinated donors. Patients with active advanced disease exhibited depressed responses to all preparations tested. The specificity of the response to secreted antigens was investigated by stimulating lymphocytes with narrow-molecular-mass fractions of short-term culture filtrate obtained by the multielution technique. Considerable heterogeneity was found within the donor groups. Patients with active minimal TB recognized multiple secreted targets, but interestingly, six of eight patients demonstrated a predominant recognition of a low-mass (< 10-kDa) protein fraction which induced high levels of gamma interferon release in vitro. Only a few of 12 previously characterized secreted antigens were recognized by T cells isolated from TB patients, suggesting the existence of a number of as yet undefined antigenic targets among secreted antigens.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7890415      PMCID: PMC173180          DOI: 10.1128/iai.63.4.1491-1497.1995

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  36 in total

1.  A simple new method for using antigens separated by polyacrylamide gel electrophoresis to stimulate lymphocytes in vitro after converting bands cut from Western blots into antigen-bearing particles.

Authors:  C Abou-Zeid; E Filley; J Steele; G A Rook
Journal:  J Immunol Methods       Date:  1987-04-02       Impact factor: 2.303

2.  Mechanism of action of an antigen nonspecific inhibitory factor produced by human T cells stimulated by MPPS and PPD.

Authors:  G Lombardi; A M Di Massimo; F Del Gallo; D Vismara; E Piccolella; O Pugliese; V Colizzi
Journal:  Cell Immunol       Date:  1986-04-01       Impact factor: 4.868

3.  Tuberculous pleural effusions. Evidence for selective presence of PPD-specific T-lymphocytes at site of inflammation in the early phase of the infection.

Authors:  G A Rossi; B Balbi; F Manca
Journal:  Am Rev Respir Dis       Date:  1987-09

4.  Effects of diet and genetics on Mycobacterium bovis BCG vaccine efficacy in inbred guinea pigs.

Authors:  M K Cohen; R A Bartow; C L Mintzer; D N McMurray
Journal:  Infect Immun       Date:  1987-02       Impact factor: 3.441

5.  Importance of thymus-derived lymphocytes in cell-mediated immunity to infection.

Authors:  R J North
Journal:  Cell Immunol       Date:  1973-04       Impact factor: 4.868

6.  Transfer of adoptive immunity to tuberculosis in mice.

Authors:  M J Lefford
Journal:  Infect Immun       Date:  1975-06       Impact factor: 3.441

7.  Genetic regulation of resistance to intracellular pathogens.

Authors:  E Skamene; P Gros; A Forget; P A Kongshavn; C St Charles; B A Taylor
Journal:  Nature       Date:  1982-06-10       Impact factor: 49.962

8.  Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins.

Authors:  P Andersen
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

9.  Specific lymphoproliferation, gamma interferon production, and serum immunoglobulin G directed against a purified 32 kDa mycobacterial protein antigen (P32) in patients with active tuberculosis.

Authors:  K Huygen; J P Van Vooren; M Turneer; R Bosmans; P Dierckx; J De Bruyn
Journal:  Scand J Immunol       Date:  1988-02       Impact factor: 3.487

10.  Antigen responsiveness during tuberculosis: regulatory interactions of T cell subpopulations and adherent cells.

Authors:  M E Kleinhenz; J J Ellner
Journal:  J Lab Clin Med       Date:  1987-07
View more
  55 in total

1.  Protection of mice with a tuberculosis subunit vaccine based on a fusion protein of antigen 85b and esat-6.

Authors:  A Weinrich Olsen; L A van Pinxteren; L Meng Okkels; P Birk Rasmussen; P Andersen
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

2.  Identification of distinct lymphocyte subsets responding to subcellular fractions of Mycobacterium bovis bacille calmette-Guérin (BCG).

Authors:  G Batoni; S Esin; M Pardini; D Bottai; S Senesi; H Wigzell; M Campa
Journal:  Clin Exp Immunol       Date:  2000-02       Impact factor: 4.330

3.  In situ activation of helper T cells in the lung.

Authors:  B Raju; C F Tung; D Cheng; N Yousefzadeh; R Condos; W N Rom; D B Tse
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

4.  Genetic regulation of acquired immune responses to antigens of Mycobacterium tuberculosis: a study of twins in West Africa.

Authors:  A Jepson; A Fowler; W Banya; M Singh; S Bennett; H Whittle; A V Hill
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

5.  Protective effect of a tuberculosis subunit vaccine based on a fusion of antigen 85B and ESAT-6 in the aerosol guinea pig model.

Authors:  Anja W Olsen; Ann Williams; Limei M Okkels; Graham Hatch; Peter Andersen
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

6.  In vitro levels of interleukin 10 (IL-10) and IL-12 in response to a recombinant 32-kilodalton antigen of Mycobacterium bovis BCG after treatment for tuberculosis.

Authors:  V Hari Sai Priya; B Anuradha; Suman Latha Gaddam; Seyed E Hasnain; K J R Murthy; Vijaya Lakshmi Valluri
Journal:  Clin Vaccine Immunol       Date:  2008-11-05

Review 7.  Antigens for CD4 and CD8 T cells in tuberculosis.

Authors:  Cecilia S Lindestam Arlehamn; David Lewinsohn; Alessandro Sette; Deborah Lewinsohn
Journal:  Cold Spring Harb Perspect Med       Date:  2014-05-22       Impact factor: 6.915

8.  A novel vaccine p846 encoding Rv3615c, Mtb10.4, and Rv2660c elicits robust immune response and alleviates lung injury induced by Mycobacterium infection.

Authors:  Hongmei Kong; Chunsheng Dong; Sidong Xiong
Journal:  Hum Vaccin Immunother       Date:  2013-11-26       Impact factor: 3.452

9.  Molecular cloning, expression, and immunogenicity of MTB12, a novel low-molecular-weight antigen secreted by Mycobacterium tuberculosis.

Authors:  J R Webb; T S Vedvick; M R Alderson; J A Guderian; S S Jen; P J Ovendale; S M Johnson; S G Reed; Y A Skeiky
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

10.  Analysis of predicted CD8+ T cell epitopes from proteins encoded by the specific RD regions of Mycobacterium tuberculosis for vaccine development and specific diagnosis.

Authors:  Jiuling Wang; Hongmei Zhang; Honghai Wang
Journal:  Mol Biol Rep       Date:  2009-07-17       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.